Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Ordinary shares, par value 0.002 GBP per share
-
Shares outstanding
-
147M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
71.8M
-
Shares change
-
+40.7K
-
Total reported value, excl. options
-
$289M
-
Value change
-
-$809K
-
Number of buys
-
11
-
Number of sells
-
-17
-
Price
-
$4.02
Significant Holders of Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) as of Q3 2022
42 filings reported holding CNTA - Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share as of Q3 2022.
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.8M shares
of 147M outstanding shares and own 48.74% of the company stock.
Largest 10 shareholders include Medicxi Ventures Management (Jersey) Ltd (20M shares), Index Venture Life Associates VI Ltd (9.96M shares), GENERAL ATLANTIC, L.P. (9.68M shares), BVF INC/IL (6.89M shares), Vida Ventures Advisors, LLC (3.93M shares), EcoR1 Capital, LLC (3.24M shares), JANUS HENDERSON GROUP PLC (2.94M shares), OUP Management Co., LLC (2.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.45M shares), and Cormorant Asset Management, LP (1.97M shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.